Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Sent an email to Robert Fairfall regarding New Ticker!!

<< Previous

Bullboard Posts

Next >>

Comment by PowerofNowon Mar 16, 2021 3:22pm

146 Views

Post# 32809486

RE:Sent an email to Robert Fairfall regarding New Ticker!!

PERFECT !!! Looks like ticker CLA is available would suit

Chritters wrote:

You sent Today at 3:15 PM

Robert Farrell Tue 2021-03-16 3:03 PM Hello Chris, Yes. we have applied for a new ticker symbol, and hope to have it approved soon. Best regards, Bob From: Chris Sadler <> Sent: Tuesday, March 16, 2021 11:49 AM To: Robert Farrell
Subject: Congrats on Unhalting and new Name Hey Robert it's been a longgg 7 months but nice to see this Un Halted and a New name come into play, Are we going to get a New Ticker Symbol soon. Hope you and your family are staying safe and well Regards